PE109598A1 - Pirrolcarboxamidas condensadas, utiles como ligandos de receptores cerebrales gaba - Google Patents

Pirrolcarboxamidas condensadas, utiles como ligandos de receptores cerebrales gaba

Info

Publication number
PE109598A1
PE109598A1 PE1997000785A PE00078597A PE109598A1 PE 109598 A1 PE109598 A1 PE 109598A1 PE 1997000785 A PE1997000785 A PE 1997000785A PE 00078597 A PE00078597 A PE 00078597A PE 109598 A1 PE109598 A1 PE 109598A1
Authority
PE
Peru
Prior art keywords
alkyl
useful
pyrolcarboxamides
leagues
condensed
Prior art date
Application number
PE1997000785A
Other languages
English (en)
Inventor
Alan Hutchison
Liu Gang
Pamela Albaugh
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of PE109598A1 publication Critical patent/PE109598A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: "W" ES ARILO O HETEROARILO, DE PREFERENCIA ES "G", EN DONDE "G" ES TIENILO, TIAZOLILO, PIRIDILO, NAFTIRIDILO, QUINOLINILO o FENILO, LOS CUALES ESTAN OPCIONALMENTE HASTA TRES VECES SUSTITUIDOS POR HALOGENO, ALQUILO, ALCOXILO o OH; "T" ES H, HALOGENO, OH, NH2 o ALCOXILO; "X" ES H, OH o ALCOXILO; m Y n SON 0; 1 o 2, DE PREFERENCIA SON 1; R3 Y R4 SON H, ALQUILO, COR5, CO2R5, CONR6R7, o R3 Y R4 FORMAN UN CICLO C3-C7; R5 ES ALQUILO o CICLOALQUILO C3-C7; R6 Y R7 SON H, ALQUILO, CICLOALQUILO C3-C7, FENILO, PIRIDILO o NR6R7 FORMAN UN GRUPO HETEROCICLICO QUE ES MORFOLINILO, PIPERIDINILO, PIRROLIDINILO o N-ALQUILO-PIPERAZINILO; DE PREFERENCIA R3 Y R4 SON H o METILO. LOS COMPUESTOS DE FORMULA (I) ACTUAN COMO AGONISTAS, ANTAGONISTAS o AGONISTAS INVERSOS DE LOS RECEPTORES CEREBRALES DEL ACIDO GAMMA-AMINOBUTIRICO (GABA), SIENDO UTILES EN EL DIAGNOSTICO Y TRATAMIENTO DE LA ANSIEDAD, SUENO Y EPILEPSIA
PE1997000785A 1996-03-22 1997-09-04 Pirrolcarboxamidas condensadas, utiles como ligandos de receptores cerebrales gaba PE109598A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62093996A 1996-03-22 1996-03-22
PCT/US1997/004623 WO1997034870A1 (en) 1996-03-22 1997-03-20 Certain fused pyrrolecarboxamides as gaba brain receptor ligands

Publications (1)

Publication Number Publication Date
PE109598A1 true PE109598A1 (es) 1999-01-16

Family

ID=24488030

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000785A PE109598A1 (es) 1996-03-22 1997-09-04 Pirrolcarboxamidas condensadas, utiles como ligandos de receptores cerebrales gaba

Country Status (7)

Country Link
US (2) US6353109B2 (es)
EP (1) EP0888300A1 (es)
AU (1) AU2218997A (es)
PA (1) PA8438301A1 (es)
PE (1) PE109598A1 (es)
TN (1) TNSN97158A1 (es)
WO (1) WO1997034870A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2218997A (en) * 1996-03-22 1997-10-10 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands
PT1030838E (pt) * 1997-11-13 2003-03-31 Pfizer Prod Inc Metodo de sintese de pirrolamidas
GT199800179A (es) * 1997-11-13 2000-05-02 Procedimiento de sintesis de pirrol amidas.
US6156898A (en) * 1998-02-26 2000-12-05 Neurogen Corporation Substituted 1,4-dihydro-4-oxonicotinic carboxamides; GABA brain receptor ligands
WO1999043661A2 (en) * 1998-02-26 1999-09-02 Neurogen Corporation Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
GB9812038D0 (en) * 1998-06-04 1998-07-29 Merck Sharp & Dohme Therapeutic compound
GB9900222D0 (en) * 1999-01-06 1999-02-24 Merck Sharp & Dohme Therapeutic compounds
CA2364652A1 (en) 1999-02-22 2000-08-31 Benoit Bachand [1,8] naphthyridine derivatives having antiviral activity
IL147971A0 (en) 1999-08-31 2002-09-12 Neurogen Corp Fused pyrrolecarboxamides: gaba brain receptor ligands
WO2001092257A1 (en) * 2000-05-26 2001-12-06 Neurogen Corporation Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands
EP1339681A1 (en) * 2000-12-04 2003-09-03 Pfizer Products Inc. Synthesis of fused pyrrolecarboxamides
US6861529B2 (en) * 2001-07-06 2005-03-01 Pfizer Inc Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
US6852730B2 (en) * 2002-02-07 2005-02-08 Neurogen Corporation Substituted fused pyrazolecarboxylic acid arylamides and related compounds
FR2863169B1 (fr) * 2003-12-08 2006-02-10 Air Liquide Sante Int Medicament gazeux inhalable a base d'argon pour le traitement des neuro-intoxications
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2026813A2 (en) 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
EP2074123B1 (en) 2006-10-16 2012-12-05 Bionomics Limited Novel anxiolytic compounds
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2681198A4 (en) 2011-03-02 2014-09-03 Bionomics Ltd NEW LITTLE MOLECULES AS THERAPIES
WO2012151640A1 (en) 2011-05-12 2012-11-15 Bionomics Limited Methods for preparing naphthyridines

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455943A (en) 1966-10-21 1969-07-15 American Cyanamid Co Certain 5,8-dihydro-beta-carbolines
US4075343A (en) 1976-09-13 1978-02-21 Pfizer Inc. Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
DE3029980A1 (de) 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indolderivate und verfahren zu ihrer herstellung
JPS57123180A (en) 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3147276A1 (de) 1981-11-28 1983-06-09 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von indolderivaten, deren verwendung als wertvolle zwischenprodukte und neue 4-hydroxyindole
DE3246932A1 (de) 1982-12-16 1984-06-20 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte 5h-pyrimido(5,4-b)indole
DE3335323A1 (de) 1983-09-27 1985-04-04 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3535927A1 (de) 1985-10-04 1987-04-09 Schering Ag 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
JPH06502147A (ja) 1990-10-09 1994-03-10 ニューロゲン　コーポレイション 或る種のシクロアルキルおよびアザシクロアルキルピロロピリミジン；新規な種類のｇａｂａ脳リセプタリガンド
US5243049A (en) 1992-01-22 1993-09-07 Neurogen Corporation Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
AU3443493A (en) 1992-02-19 1993-09-13 Upjohn Company, The 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity
US5266698A (en) 1992-04-30 1993-11-30 Neurogen Corporation Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
WO1994017095A1 (en) 1993-01-29 1994-08-04 Ariad Pharmaceuticals, Inc. Analogs of receptor tyrosine activation motifs and therapeutic uses thereof
US5750702A (en) 1993-10-27 1998-05-12 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
US5484944A (en) * 1993-10-27 1996-01-16 Neurogen Corporation Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
AU2218997A (en) * 1996-03-22 1997-10-10 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands

Also Published As

Publication number Publication date
US6720339B2 (en) 2004-04-13
WO1997034870A1 (en) 1997-09-25
US20010020035A1 (en) 2001-09-06
US6353109B2 (en) 2002-03-05
US20020198204A1 (en) 2002-12-26
AU2218997A (en) 1997-10-10
PA8438301A1 (es) 2000-05-24
EP0888300A1 (en) 1999-01-07
TNSN97158A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
PE109598A1 (es) Pirrolcarboxamidas condensadas, utiles como ligandos de receptores cerebrales gaba
PE91798A1 (es) Pirrolicarboxanilidas condensadas: utiles como ligandos receptores
PE46899A1 (es) Derivados de n-fenil-sulfonamida
DK0640592T3 (da) N-acylerede tricycliske azaheteroringe anvendelige som vasopressin-antagonister
AR019626A1 (es) Antagonistas receptores y5 de neuropeptidos.
AR054035A1 (es) Derivados benzodioxano y benzodioxolano y uso de los mismos
AR004516A1 (es) Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen
PE20020062A1 (es) 5-AMINO-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PIRIMIDINA COMO ANTAGONISTAS RECEPTORES DE ADENOSINA A2a
AR032436A1 (es) Oxazolidinonas substituidas, procedimiento para su preparacion, medicamentos, el uso de las mismas para la fabricacion de medicamentos, y el metodo para impedir la coagulacion sanguinea in vitro
AR240929A2 (es) "n-piridinsulfonil-n'-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas"
AR017807A1 (es) COMPUESTOS CON ACTIVIDAD SELECTIVA EN LOS SUBTIPOS DE RECEPTOR ADRENÉRGICO ALFA 2B o ALFA 2B Y ALFA 2C Y SUS USOS EN LA MANUFACTURA DE UN MEDICAMENTO
BR122012009489B8 (pt) processo para produzir 2-etóxi-1-{[2’-(5-oxo-4,5-diidro-1,2,4-oxadiazol-3-il)bifenil-4-il]metil}-1h-benzimidazol-7-carboxilato de (5-metil-2-oxo-1,3-dioxol-4-il)metila ou um sal do mesmo, composição farmacéutica, e, uso
ECSP034475A (es) Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1
AR029301A1 (es) Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos
PE20050420A1 (es) Fenacilo 2-hidroxi-3-diaminoalcanos
PE20021067A1 (es) Empleo de antagonistas del receptor nk3
AR037907A1 (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
AR035235A1 (es) Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
CY1109808T1 (el) Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α
SE9702564D0 (sv) New compounds
AR037906A1 (es) Derivados de indolilalquilamina como ligandos de 5-hidroxitriptamina-6
CA2207784A1 (en) Certain pyrrolopyridine derivatives; novel crf1 specific ligands
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
ES2073396T3 (es) Nuevos derivados ciclicos del acido antranilico y procedimiento para su preparacion.
BR0308780A (pt) Composto, processo para a preparação e uso do mesmo, método para o tratamento de um sujeito humano ou animal que sofre de, ou que é suscetìvel a, uma condição inflamatória, e, composição farmacêutica

Legal Events

Date Code Title Description
FA Abandonment or withdrawal